Last $0.04 USD
Change Today 0.00 / 0.00%
Volume 0.0
HTLZF On Other Exchanges
Symbol
Exchange
Venture
OTC US
As of 8:10 PM 03/17/14 All times are local (Market data is delayed by at least 15 minutes).

hamilton thorne ltd (HTLZF) Snapshot

Open
$0.04
Previous Close
$0.04
Day High
$0.04
Day Low
$0.04
52 Week High
07/10/13 - $0.20
52 Week Low
04/29/13 - $0.04
Market Cap
2.1M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
52.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HAMILTON THORNE LTD (HTLZF)

Related News

No related news articles were found.

hamilton thorne ltd (HTLZF) Related Businessweek News

No Related Businessweek News Found

hamilton thorne ltd (HTLZF) Details

Hamilton Thorne Ltd., through its wholly owned subsidiary, Hamilton Thorne, Inc., develops, manufactures, and sells precision laser systems and advanced image analysis systems for living cell applications in the fertility, stem cell, and developmental biology research markets. Its product portfolio consists of XYRCOS for clinical laser assisted hatching and biopsy applications in animal and stem cell; XYClone laser system for stem cell research, gene targeting, knock out mouse production, SCNT, ICSI, IVF, and assisted hatching; ZILOS-tk for laser assisted hatching, trophectoderm biopsy, and blastomere biopsy for clinical human applications; LYKOS laser with built-in RED-i target locator for clinical applications; and Stiletto for ablation of unwanted cells. The company also offers IMSI-Strict software solution that offers real-time, automated computer analysis of live sperm morphology under high magnification; and CIVA, a custom software product for the capture of microscope images and videos. In addition, it provides computer assisted sperm analyzers, as well as sperm analysis accessories, including Accu-beads for quality control of sperm counting, IDENT fluorescent stain for precise sperm counts, VIADENT fluorescent stains for viability studies, 2X-CEL disposable sperm analysis chambers, and the MiniTherm portable stage warmer. Further, the company offers micromanipulation products, such as XenoWorks Micromanipulator, XenoWorks Digital Microinjector, and XenoWorks Analog Microinjector, as well as micropipette puller, laser based micropipette puller, flaming/brown micropipette puller, and vertical micropipette puller. Hamilton Thorne Ltd. sells its products through its direct sales force and through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments worldwide. The company was founded in 2001 and is based in Beverly, Massachusetts.

hamilton thorne ltd (HTLZF) Top Compensated Officers

Chief Executive officer, President and Direct...
Total Annual Compensation: $184.5K
Co-Founder, Chief Technology Officer, Senior ...
Total Annual Compensation: $138.8K
Co-Founder and Chairman of the Board
Total Annual Compensation: $68.1K
Chief Financial Officer and Vice President of...
Total Annual Compensation: $152.0K
Vice President of Engineering
Total Annual Compensation: $140.0K
Compensation as of Fiscal Year 2012.

hamilton thorne ltd (HTLZF) Key Developments

Hamilton Thorne Ltd. Releases Version 1.5 of its Casa II Sperm Analysis Software

Hamilton Thorne Ltd. announced the release of Version 1.5 of its CASA II sperm analysis software. First released to the animal breeding market in late 2012 and introduced to the fertility market at the European Society of Human Reproduction and Embryology (ESHRE) annual meeting in July 2013, the CASA II software is a complete revitalization of the company's legacy CASA software. The redesigned software interface provides users with a streamlined workflow and offers automated features to enhance analysis accuracy and ease of use. New features include: computer controlled auto-illumination to precisely and reliably set illumination to the correct level and eliminate guesswork by the user; digital debris filter for best identification of static cells (prevents debris from being labeled as a non-motile cell); interactive color-coded settings for sperm head and tail identification to ensure analysis accuracy and consistency across all users; automated settings for tail detection based on background illumination level; and database management utilities to simplify data management, maintain data integrity and provide data optimization. The CASA II software runs on the company's proprietary IVOS II and CEROS II hardware platforms. These systems utilize a high resolution digital camera and microscope optics to capture images of live cells from which the CASA II software determines cell counts and concentrations, tracks and analyzes cell motion, measures morphometric characteristics, and provides output data specific to individual markets. Several software and hardware options are also available to add higher level functionality.

Hamilton Thorne Ltd. Provides Preliminary Unaudited Financial Guidance for the Fourth Quarter and Year-Ended December 31, 2013

Hamilton Thorne Ltd. provided preliminary unaudited financial guidance for the fourth quarter and year-ended December 31, 2013. For the year annual sales increased 18% to approximately $7.5 million, company generated positive EBITDA for the year of approximately $400,000. For the fourth quarter sales grew 10% to approximately $2.27 million versus the same quarter last year. The company continued to generate positive quarterly net income and cash flow due to the combination of strong sales and the full impact of the strategic cost cutting that executed in 2012.

Hamilton Thorne Ltd. Announces Earnings Results for the Third Quarter and Nine Month Period Ended September 30, 2013

Hamilton Thorne Ltd. announced earnings results for the third quarter and nine month period ended September 30, 2013. For the quarter, the company’s sales increased to $1,637,846, up 13% over $1,453,524 for the prior year, led by another strong quarter for its IVOS(R) II image analysis products supported by steady sales of laser products. Net income was $7,845 against net loss of $336,825 a year ago. EBITDA was $33,938 against LBITDA of $243,303 a year ago. For the nine months, the company’s sales increased to $5,206,428, up 22% over $4,261,666 for the prior year. Net loss was $127,061 against net loss of $1,656,629 a year ago. EBITDA was $69,685 against LBITDA of $1,367,061 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HTLZF:US $0.04 USD 0.00

HTLZF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Brooks Automation Inc $11.12 USD +0.11
Tsubakimoto Chain Co ¥763.00 JPY +1.00
View Industry Companies
 

Industry Analysis

HTLZF

Industry Average

Valuation HTLZF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HAMILTON THORNE LTD, please visit www.hamiltonthorne.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.